Highlighting the potential of PTH1R receptor agonist therapy in autosomal dominant hypocalcemia type 1

https://doi.org/10.1172/JCI201759 In this Research Letter, Rajesh V. Thakker & team report on the use of Eneboparatide in mice with ADH1, which increased serum calcium levels without increasing urine calcium.

³Mary Lyon Centre, MRC Harwell, Harwell Science and Innovation Campus, Oxfordshire, United Kingdom.

⁴Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

⁵William Harvey Research Institute, London School of Medicine, Queen Mary University of London, London, United Kingdom.